Epithelial cell fate following lung injury

References

• Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol.9, 378–390 (2008).
   PubMed Web of Science ®Google Scholar
• Tang PS, Mura M, Seth R et al. Acute lung injury and cell death: how many ways can cells die? Am. J. Physiol. Lung Cell Mol. Physiol.294, L632–L641 (2008).
   PubMed Web of Science ®Google Scholar
• Kroemer G, Reed JC. Mitochondrial control of cell death. Nat. Med.6, 513–519 (2000).
   PubMed Web of Science ®Google Scholar
• Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol.3, 255–263 (2001).
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell132, 27–42 (2008).
   PubMed Web of Science ®Google Scholar
• Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med.3, 35–56 (1982).
   PubMed Web of Science ®Google Scholar
• Bardales RH, Xie SS, Schaefer RF, Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol.149, 845–852 (1996).
   PubMed Web of Science ®Google Scholar
• Guinee D Jr, Brambilla E, Fleming M et al. The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am. J. Pathol.151, 999–1007 (1997).
   PubMed Web of Science ®Google Scholar
• Guinee D Jr, Fleming M, Hayashi T et al. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am. J. Pathol.149, 531–538 (1996).
   PubMed Web of Science ®Google Scholar
• Albertine KH, Soulier MF, Wang Z et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Pathol.161, 1783–1796 (2002).
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Liles WC, Steinberg KP et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol.163, 2217–2225 (1999).
   PubMed Web of Science ®Google Scholar
• Hagimoto N, Kuwano K, Miyazaki H et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol.17, 272–278 (1997).
   PubMed Web of Science ®Google Scholar
• Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med.186, 1831–1841 (1997).
   PubMed Web of Science ®Google Scholar
• Kawasaki M, Kuwano K, Hagimoto N, et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am. J. Pathol.157, 597–603 (2000).
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Hashimoto S, Mizuta N et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med.163, 762–769 (2001).
   PubMed Web of Science ®Google Scholar
• Tang PS, Tsang ME, Lodyga M, et al. Lipopolysaccharide accelerates caspase-independent but cathepsin B-dependent death of human lung epithelial cells. J. Cell. Physiol.209, 457–467 (2006).
   PubMed Web of Science ®Google Scholar
• Roper JM, Mazzatti DJ, Watkins RH et al.In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol.286, 1045–1054 (2004).
   PubMed Web of Science ®Google Scholar
• Tateda K, Deng JC, Moore TA et al. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol.170, 4209–4216 (2003).
   PubMed Web of Science ®Google Scholar
• Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit. Care11, 25 (2007).
   Google Scholar
• Husari AW, Dbaibo GS, Bitar H et al. Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir. Res.26, 107–100 (2006).
   Google Scholar
• Bhandari V, Choo-Wing R, Lee CG et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat. Med.12, 1286–1293 (2006).
   PubMed Web of Science ®Google Scholar
• Mura M, Andrade CF, Han B et al. Intestinal ischemia–reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock28(2), 227–238 (2007).
   PubMed Web of Science ®Google Scholar
• Rivo J, Zeira E, Galun E et al. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock27, 266–273 (2007).
   PubMed Web of Science ®Google Scholar
• Tipple TE, Welty SE, Rogers LK et al. Thioredoxin-related mechanisms in hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol.37(4), 405–413 (2007).
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Kolls JK, Mantell LL et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest.103, 1047–1054 (1999).
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol.276, 688–694 (1999).
   PubMed Web of Science ®Google Scholar
• Otterbein LE, Otterbein SL, Ifedigbo E et al. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am. J. Pathol.163, 2555–2563 (2003).
   PubMed Web of Science ®Google Scholar
• Kuwano K, Kunitake R, Kawasaki M et al. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.154, 477–483 (1996).
   PubMed Web of Science ®Google Scholar
• Uhal BD, Joshi I, Hughes WF et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol.275, 1192–1199 (1998).
   PubMed Web of Science ®Google Scholar
• Barbas-Filho JV, Ferreira MA, Sesso A et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J. Clin. Pathol.54, 131–138 (2001).
   Google Scholar
• Kuwano K, Miyazaki H, Hagimoto N et al. The involvement of Fas–Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol.20, 53–60 (1999).
   PubMed Web of Science ®Google Scholar
• Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol.16, 91–101 (1997).
   PubMed Web of Science ®Google Scholar
• Kuwano K, Hagimoto N, Kawasaki M et al. Essential roles of the Fas–Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest.104, 13–19 (1999).
   PubMed Web of Science ®Google Scholar
• Kuwano K, Kunitake R, Maeyama T et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol.280, 316–325 (2001).
   PubMed Web of Science ®Google Scholar
• Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol.279, 143–151 (2000).
   PubMed Web of Science ®Google Scholar
• Golan-Gerstl R, Wallach-Dayan SB, Amir G, Breuer R. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis. Am. J. Respir. Cell Mol. Biol.36, 270–275 (2007).
   PubMed Web of Science ®Google Scholar
• Ko LJ, Prives C. p53 puzzle and paradigm. Genes Dev.10, 1054–1072 (1996).
   PubMed Web of Science ®Google Scholar
• Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res.51, 6304–6311 (1991).
   PubMed Web of Science ®Google Scholar
• Mishra A, Doyle NA, Martin WJ 2nd. Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am. J. Respir. Cell Mol. Biol.22, 543–549 (2000).
   PubMed Web of Science ®Google Scholar
• Kuwano K, Hagimoto N, Tanaka T et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J. Pathol.190, 21–29 (2000).
   Google Scholar
• Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature371, 534–537 (1994).
   PubMed Web of Science ®Google Scholar
• Lu Y, Yamagishi N, Yagi T, Takebe H. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene16, 705–712 (1998).
   PubMed Web of Science ®Google Scholar
• Bissonnette N, Hunting DJ. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene16, 3461–3469 (1998).
   PubMed Web of Science ®Google Scholar
• O’Reilly MA, Staversky RJ, Watkins RH et al. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am. J. Respir. Cell Mol. Biol.24, 703–710 (2001).
   PubMed Web of Science ®Google Scholar
• Staversky RJ, Watkins RH, Wright TW, et al. Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am. J. Pathol.161, 1383–1393 (2002).
   PubMed Web of Science ®Google Scholar
• Inoshima I, Kuwano K, Hamada N et al. Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol.286, 727–733 (2004).
   Google Scholar
• Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene17, 931–939 (1998).
   PubMed Web of Science ®Google Scholar
• Suzuki A, Tsutomi Y, Miura M, Akahane K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene18, 1239–1244 (1999).
   PubMed Web of Science ®Google Scholar
• Wang R, Zagariya A, Ibarra-Sunga O et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am. J. Physiol.276, 885–889 (1999).
   PubMed Web of Science ®Google Scholar
• Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am. J. Physiol.277, 1245–1250 (1999).
   PubMed Web of Science ®Google Scholar
• Wang R, Alam G, Zagariya A et al. Apoptosis of lung epithelial cells in response to TNF-α requires angiotensin II generation de novo. J. Cell. Physiol.185, 253–259 (2000).
   PubMed Web of Science ®Google Scholar
• Ward WF, Molteni A, Ts’ao CH, Hinz JM. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int. J. Radiat. Oncol. Biol. Phys.19, 1405–1409 (1990).
   PubMed Web of Science ®Google Scholar
• Li X, Molina-Molina M, Abdul-Hafez A et al. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol.291, 887–895 (2006).
   PubMed Web of Science ®Google Scholar
• Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am. J. Pathol.163, 2523–2530 (2003).
   PubMed Web of Science ®Google Scholar
• Hagimoto N, Kuwano K, Inoshima I et al. TGF-β 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol.168, 6470–6478 (2002).
   PubMed Web of Science ®Google Scholar
• Kang HR, Cho SJ, Lee CG, Homer RJ, Elias JA. Transforming growth factor (TGF)-β1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J. Biol. Chem.282, 7723–7732 (2007).
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Wurfel MM, Lee JS et al. Essential role of MMP-12 in fas-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol.37(2), 210–221 (2007).
   PubMed Web of Science ®Google Scholar
• Tuder RM, Yoshida T, Fijalkowka I, Biswal S, Petrache I. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc. Am. Thorac. Soc.3, 673–679 (2006).
   PubMedGoogle Scholar
• Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med.350, 2645–2653 (2004).
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol.28, 555–562 (2003).
   PubMed Web of Science ®Google Scholar
• Petrache I, Fijalkowska I, Medler TR et al. α-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol.169, 1155–1166 (2006).
   PubMed Web of Science ®Google Scholar
• Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab. Invest.82, 79–85 (2002).
   PubMed Web of Science ®Google Scholar
• Elias JA, Kang MJ, Crothers K et al. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc. Am. Thorac. Soc.3, 494–498 (2006).
   PubMedGoogle Scholar
• Kang MJ, Homer RJ, Gallo A et al. IL-18 is induced and IL-18 receptor α plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J. Immunol.178, 1948–1959 (2007).
   PubMed Web of Science ®Google Scholar
• van der Toorn M, Slebos DJ, de Bruin HG et al. Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am. J. Physiol. Lung Cell Mol. Physiol.292, 1211–1218 (2007).
   PubMed Web of Science ®Google Scholar
• Slebos DJ, Ryter SW, van der Toorn M et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am. J. Respir. Cell Mol. Biol.26, 409–417 (2007).
   Google Scholar
• Castillo SS, Levy M, Wang C et al. Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis. Exp. Cell Res.313, 816–823 (2007).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest.106, 1311–1319 (2000).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Cool CD et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med.163, 737–744 (2001).
   PubMed Web of Science ®Google Scholar
• Henson PM, Vandivier RW, Douglas IS. Cell death, remodeling and repair in chronic obstructive pulmonary disease? Proc. Am. Thorac. Soc.3, 713–717 (2006).
   PubMedGoogle Scholar
• Clark H, Palaniyar N, Strong P et al. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J. Immunol.169, 2892–2899 (2002).
   PubMed Web of Science ®Google Scholar
• Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest125, 626–632 (2004).
   PubMed Web of Science ®Google Scholar
• Carnevali S, Petruzzelli S, Longoni B et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol.284, 955–963 (2003).
   PubMed Web of Science ®Google Scholar
• Gauldie J, Kolb M, Ask K et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc. Am. Thorac. Soc.3(8), 696–702 (2006).
   PubMedGoogle Scholar